These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30738036)

  • 21. Enhancement of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Relevance for neuroplasticity and depression.
    Borroto-Escuela DO; Pérez-Alea M; Narvaez M; Tarakanov AO; Mudó G; Jiménez-Beristain A; Agnati LF; Ciruela F; Belluardo N; Fuxe K
    Biochem Biophys Res Commun; 2015 Jul; 463(3):180-6. PubMed ID: 25957476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments.
    Mori MA; Meyer E; da Silva FF; Milani H; Guimarães FS; Oliveira RMW
    Eur J Neurosci; 2021 Mar; 53(6):1738-1751. PubMed ID: 33522084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of cannabinoid signaling in microglia by adenosine A
    Franco R; Reyes-Resina I; Aguinaga D; Lillo A; Jiménez J; Raïch I; Borroto-Escuela DO; Ferreiro-Vera C; Canela EI; Sánchez de Medina V; Del Ser-Badia A; Fuxe K; Saura CA; Navarro G
    Glia; 2019 Dec; 67(12):2410-2423. PubMed ID: 31429130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the role of heteroreceptor complexes in the central nervous system.
    Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
    Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxetine and Low-dose Risperidone Induce Serotonin 5-HT
    Kolasa M; Solich J; Faron-Górecka A; Żurawek D; Pabian P; Łukasiewicz S; Kuśmider M; Szafran-Pilch K; Szlachta M; Dziedzicka-Wasylewska M
    Neuroscience; 2018 May; 377():184-196. PubMed ID: 29544901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antagonization of OX
    Raïch I; Rebassa JB; Lillo J; Cordomi A; Rivas-Santisteban R; Lillo A; Reyes-Resina I; Franco R; Navarro G
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabigerol Action at Cannabinoid CB
    Navarro G; Varani K; Reyes-Resina I; Sánchez de Medina V; Rivas-Santisteban R; Sánchez-Carnerero Callado C; Vincenzi F; Casano S; Ferreiro-Vera C; Canela EI; Borea PA; Nadal X; Franco R
    Front Pharmacol; 2018; 9():632. PubMed ID: 29977202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk between receptor tyrosine kinases (RTKs) and G protein-coupled receptors (GPCR) in the brain: Focus on heteroreceptor complexes and related functional neurotrophic effects.
    Di Liberto V; Mudò G; Belluardo N
    Neuropharmacology; 2019 Jul; 152():67-77. PubMed ID: 30445101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease.
    Borroto-Escuela DO; Carlsson J; Ambrogini P; Narváez M; Wydra K; Tarakanov AO; Li X; Millón C; Ferraro L; Cuppini R; Tanganelli S; Liu F; Filip M; Diaz-Cabiale Z; Fuxe K
    Front Cell Neurosci; 2017; 11():37. PubMed ID: 28270751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR1-5-HT1A Heteroreceptor Complexes: Implications for Understanding and Treating Major Depression.
    Borroto-Escuela DO; Tarakanov AO; Fuxe K
    Trends Neurosci; 2016 Jan; 39(1):5-15. PubMed ID: 26687454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a CB
    Yang W; Gong X; Sun H; Wu C; Suo J; Ji J; Jiang X; Shen J; He Y; Aisa HA
    Eur J Med Chem; 2024 Feb; 265():116048. PubMed ID: 38150961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
    Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
    Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies.
    Łukasiewicz S; Błasiak E; Szafran-Pilch K; Dziedzicka-Wasylewska M
    J Neurochem; 2016 May; 137(4):549-60. PubMed ID: 26876117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5-HT1A receptor: Signaling to behavior.
    Albert PR; Vahid-Ansari F
    Biochimie; 2019 Jun; 161():34-45. PubMed ID: 31079617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The functional cooperation of 5-HT
    Burnat G; Brański P; Solich J; Kolasa M; Chruścicka B; Dziedzicka-Wasylewska M; Pilc A
    Pharmacol Rep; 2020 Oct; 72(5):1358-1369. PubMed ID: 32472388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.
    Martínez-Pinilla E; Reyes-Resina I; Oñatibia-Astibia A; Zamarbide M; Ricobaraza A; Navarro G; Moreno E; Dopeso-Reyes IG; Sierra S; Rico AJ; Roda E; Lanciego JL; Franco R
    Exp Neurol; 2014 Nov; 261():44-52. PubMed ID: 24967683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
    Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.
    Pérez-Gómez E; Andradas C; Blasco-Benito S; Caffarel MM; García-Taboada E; Villa-Morales M; Moreno E; Hamann S; Martín-Villar E; Flores JM; Wenners A; Alkatout I; Klapper W; Röcken C; Bronsert P; Stickeler E; Staebler A; Bauer M; Arnold N; Soriano J; Pérez-Martínez M; Megías D; Moreno-Bueno G; Ortega-Gutiérrez S; Artola M; Vázquez-Villa H; Quintanilla M; Fernández-Piqueras J; Canela EI; McCormick PJ; Guzmán M; Sánchez C
    J Natl Cancer Inst; 2015 Jun; 107(6):djv077. PubMed ID: 25855725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional CB2 type cannabinoid receptors at CNS synapses.
    Morgan NH; Stanford IM; Woodhall GL
    Neuropharmacology; 2009 Sep; 57(4):356-68. PubMed ID: 19616018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-Dependent Protection of CB2 Receptor Agonist in Stroke.
    Yu SJ; Reiner D; Shen H; Wu KJ; Liu QR; Wang Y
    PLoS One; 2015; 10(7):e0132487. PubMed ID: 26186541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.